SKUYF yields 4.96% · PFE yields 6.13%● Live data
📍 SKUYF pulled ahead of the other in Year 1
Combined, SKUYF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKUYF + PFE for your $10,000?
Sansei Technologies, Inc. plans, designs, manufactures, installs, repairs, and maintains amusement rides, stage equipment, elevators, and other designed equipment in Japan and internationally. The company's amusement rides include dark rides, mini-roller coasters, family rides and others, carousel type rides, jet-roller coasters, and flume rides. It also provides stage equipment, such as floor mechanisms comprising elevators for stage traps, sliding stages and stage wagons, inclined floors, circular-type stages, etc. In addition, the company offers rigging systems for raising and lowering the scenery, lighting, sound and screen equipment, stage curtains, acoustic panels, etc.; acoustic equipment; control systems; and stage equipment for small halls, adaptable stages, event halls, sports halls, and studios. Further, it provides property management and logistics services; operates and manages amusement facilities; and rents electric and mechanical equipment for TV programs, concerts, stages, events, etc. The company was formerly known as Sansei Yusoki Co., Ltd. and changed its name to Sansei Technologies, Inc. in January 2014. Sansei Technologies, Inc. was incorporated in 1951 and is headquartered in Osaka, Japan.
Full SKUYF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.